Abstract
(−)-Stepholidine (SPD), a novel dopamine (DA) D, and/or D 2 receptor antagonist in normosensitive animals, shows agonistic effects on D 1 receptors in rotational behavior of 6-hydroxydopamine (6-OHDA)-lesioned rats. To further characterize the pharmacological properties of SPD, we investigated the effects of SPD on firing activity of substantia nigra pars reticulata (SNR) neurons in different sensitive models. In control rats, the selective D 1 agonist SKF38393 (4 mg/kg, i.v.) induced inconsistent changes (i.e. increase, decrease or no change) in firing of SNR neurons. These effects were completely antagonized by SPD (i.v.), regardless of the changes induced by SKF38393. SPD (4 mg/kg), per se, increased firing by 30.9 ± 14.4%. In reserpinized rats, SKF38393 also induced SPD-reversible inconsistent changes as in control rats. Nevertheless, SPD per se produced no alteration in firing of SNR neurons. In 6-OHDA-lesioned rats, 5 6 SNR neurons were inhibited by SKF38393. The inhibition was completely abolished by Sch23390, a selective D 1 antagonist (0.5–2 mg/kg), but partially reversed by SPD (1–16 mg/). Moreover, SPD (4 mg/kg) itself caused SNR increased or decreased neuron firing, and these effects were completely reversed by Sch23390 (0.5–2 mg/kg) in 8 12 neurons recorded. These results suggest that SPD acts as a partial agonist to D 1 receptors in 6-OHDA-lesioned rats, but as an antagonist to D 1, receptors in normal and reserpinized rats.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.